| Active substance | Pritelivir |
| Holder | myTomorrows |
| Status | Rnning |
| Indication | treatment of acyclovir-resistant mucocutaneous HSV (Herpes Simplex Virus) infections in immunocompromised patient |
| Public documents | |
| Last update | 01/12/2022 |
Pritelivir
Last updated on 23/05/2023